IM Cannabis Corp. (IMCC)
D
Pipeline Grade
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2026-10-31 | Phase3 Readout | — |
Active Clinical Trials (3)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT02915120 | Ultrasound-Guided Pulsed Radiofrequency In The Treatment Of Patients With Osteoarthritis Knee (USPRFGENOAK) | OTHER | Recruiting | 142 |
| NCT06399822 | Impact of Capillaroscopy on the Management of Undifferentiated Connective Tissue Disease | OTHER | Recruiting | 40 |
| NCT07246187 | Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency Department | PHASE3 | Recruiting | 114 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.